Multiple Sclerosis Clinical Trial

Effects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)

Summary

To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).

View Full Description

Full Description

The purpose of this research study is to learn how different types of cycling exercise can improve short-term processing speed, or speed of thinking, in persons with MS. In this study, we will compare the effects of cycling alone to cycling with two different types of virtual reality. Participants will complete all three cycling conditions, one per week. We are studying these types of cycling because there are currently no effective treatment options to improve processing speed in persons with MS and combining exercise with virtual reality is a promising technique.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Speak English as their primary language
Confirmed MS diagnosis by a neurologist
Be relapse and steroid-free for at least 30 days
Moderate self-report mobility disability

Exclusion Criteria:

History of neurological disorders besides MS or history of uncontrolled psychiatric disorders (ex: major depression)
Have contraindications to exercise, based on the Physical Activity Readiness Questionnaire (PAR-Q)
Currently use medications that may impact cognition (ex: steroids, benzodiazepines)
Currently pregnant
Severe cognitive impairment as measured by the Modified Telephone Interview of Cognitive Status (TICS-M)
High likelihood of motion sickness
Regular cyclist, defined as cycling for at least 150 minutes/week

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

24

Study ID:

NCT06191380

Recruitment Status:

Recruiting

Sponsor:

Kessler Foundation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Kessler Foundation
East Hanover New Jersey, 07936, United States More Info
Carly Wender, PhD
Contact
973-243-6984
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

24

Study ID:

NCT06191380

Recruitment Status:

Recruiting

Sponsor:


Kessler Foundation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.